6月11日，葛兰素史克盘前上涨3.01%，报52.71美元/股，成交额81.33万美元。
消息面上，GSK于6月9日宣布以106亿美元全现金收购美国肿瘤药企Nuvalent，每股124美元的收购价较后者前一交易日收盘价溢价40%。这是GSK十余年来规模最大的一笔并购，也是新任CEO卢克·米尔斯上任后首笔重大交易。Nuvalent旗下两款肺癌靶向药已进入FDA审评阶段，预计今年9月和11月获批决定。GSK表示该交易预计从2027年起贡献营收增长，助力公司应对多款核心产品专利到期带来的"专利悬崖"压力，并重申全年核心营业利润增长7%至9%的指引不变。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.